Publication: RECOMMENDATIONS FOR NURSES IN THE MANAGEMENT OF RA PATIENTS ON TREATMENT WITH JAKINIBS
No Thumbnail Available
Identifiers
Date
2022-06-01
Authors
Martin-Martin, J. M.
Garcia-Diaz, S.
Molina, A.
Dominguez, C.
Carmona, L.
Cano-Garcia, L.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bmj publishing group
Metrics
Export
Abstract
Background: The number of new treatments available in rheumatology continues to increase. Kinase inhibitors, or jakinibs, pose an added challenge due to their variety and because they are oral. The most important role of the rheumatology nurse is patient education, especially on how to take the medication. The better the nurse understands the drugs, the better their practical recommendations and decisions will be, and the better they will be able to respond to the patient. Guidelines or recommendations for inflammatory diseases do not usually include key practical details for nurses. It is our understanding that these points, which will subsequently determine adherence and safety, should be specially addressed in a specific document for nurses.
Description
MeSH Terms
Rheumatology
Patient Education as Topic
Nurse's Role
Surveys and Questionnaires
Patient Education as Topic
Nurse's Role
Surveys and Questionnaires
DeCS Terms
Enfermeras y enfermeros
Reumatología
Preparaciones farmacéuticas
Terapéutica
Fosfotransferasas
Comprensión
Reumatología
Preparaciones farmacéuticas
Terapéutica
Fosfotransferasas
Comprensión
CIE Terms
Keywords
Therapeutics, Patients, Nurses
Citation
Martín, J. M. M., García-Díaz, S., Molina, A., Dominguez, C., Carmona, L., & Garcia, L. C. (2022). OP0213-HPR RECOMMENDATIONS FOR NURSES IN THE MANAGEMENT OF RA PATIENTS ON TREATMENT WITH JAKINIBS. Annals Of The Rheumatic Diseases, 81(Suppl 1), 139.2-139